>Year 2001, Issue 3
Calderón AM, Romero BJ, Valpuesta VVM, Uriarte BA, Sánchez VLD, Burgess VA, Negri PV
Surgical treatment of the superior vena cava syndrome. Report on four cases
Cir Gen 2001; 23 (3)
PDF: 4. Kb.
Objective: To present the surgical experience with four cases of superior vena cava obstruction .
Design: Report of cases.
Setting: Third level health care hospital.
Patients: We describe the clinical history of four patients with superior vena cava syndrome. Three men and one woman, their ages were 32, 51, 14, and 53, respectively; symptomatology had been evolving from 2 to 8 weeks, characterized by: facial and upper extremities edema and rapidly progressing dyspnea. In three patients, computed axial tomography demonstrated a vena cava tumor in one, pulmonary hilum tumor in one, and no signs in the other. Phlebographies of upper extremities demonstrated deep venous thrombosis in two patients. Final diagnoses were: Tumor due to non-Hodgkin lymphoma in one, bronchogenic carcinoma in another, and fibrosis in the superior vena cava, the innominate vena, and in the sub-clavia and internal jugular veins in two patients. They were treated by shunting the innominate or jugular vein to the right atrium using synthetic grafts (polytetrafluorethyl or Dacron) or even by venous thrombectomy. No death occurred attributable to the surgery.
Conclusion: The surgical approach can be an alternative to be used in hospitals where no resources for interventionist radiology exist.
||Superior vein cava syndrome, cardiothoracic surgery, thrombosis.
Rösch J, Uchida BT, Hall LD, Antonovic R, Petersen BD, Irancer K et al. Gianturco-Rösch expandable Z-stents in the treatment of superior vena cava syndrome. Cardiovasc Intervent Radiol 1992; 15: 319-27.
Doty BP. Bypass of superior vena cave: Six years experience with spiral vein graft for obstruction of superior vena cava due to benign or malignant disease. J Thorac Cardiovasc Surg 1982; 83: 326-38.
Hemphill DJ, Sniderman KW, Allard JP. Management of total parenteral nutrition-related superior vena cava obstruction with expandable metal stents. JPEN J Parenter Enteral Nutr 1996; 20: 222-7.
Santoro G, Squillantini G, Corti G, Dolara A. Ostruzione de la vena cava superiore intervento corretivo per ritorno venoso polmonare anomalo totale trattata con angioplastica percutanea. G Ital Cardiol 1994; 24: 1581-4.
Klima U, Mair R, Gross C, Peschl F, Wimmer-Greinecker G, Brucke P. Die Verwendung der autologen Vena femoralis bei Vena-cava-superior-Thrombose. Fallbericht mit Literaturrubersicht. Langenbecks Arch Chir 1994; 379: 120-2.
Kimura T, Chino M, Ogasawara N, Nakano T, Izumi S, Takeuchi H. Trousseau’s syndrome with brachiocephalic vein thrombosis in a patient with uterine carcinosarcoma. A case report. Angiology 1999; 50: 515-8.
Stockx L, Raat H, Donck J, Wilms G, Marchal G. Repositioning and leaving in situ the central venous catheter during percutaneous treatment of associated superior vein cava syndrome: a report of eight cases. Cardiovasc Intervent Radiol 1999; 22: 224-6.
Kroger K, Ansasy M, Rudofsky G. Postoperative thrombosis of the superior caval vein in a patient with primary asymptomatic Behcet’s disease. A case report. Angiology 1997; 48: 649-53.
Tovar-Martin E, Tovar-Pardo AE, Marini M, Pimentel Y, Rois JM. Intraluminal leiomyosarcoma of the superior vein cava: a cause of superior vein cava syndrome. J Cardiovasc Surg 1997; 38: 33-5.
Kastner RJ, Fisher WG, Blacky AR, Bacon ME. Pacemaker-induced superior vein cava syndrome with successful treatment by balloon venoplasty. Am J Cardiol 1996; 77: 789-90.
Ferro C, Scarrone A, Borrelli M, Buccheri G, Ferrigno D, Marchetti G, et al. Tratamento della sindrome della vena cava superiore con stent metallici. Esperienza preliminare. Radiol Med (Torino) 1995; 90: 457-62.
>Year 2001, Issue 3